期刊文献+

miR-21、miR-494对黑素瘤A375细胞凋亡和细胞周期的影响 被引量:4

Effect of microRNA-21 and microRNA-494 on cell cycle of and apoptosis in a human melanoma cell line A375
原文传递
导出
摘要 目的探讨miR-21抑制物和miR-494模拟物转染A375细胞的最佳有效转染浓度及其对黑素瘤A375细胞增殖的影响。方法取6个浓度梯度的miR-21抑制物和miR-494模拟物转染A375细胞,实时荧光定量PCR法检测相应的miRNA。继而用Cy5标记的miRNA模拟物阴性对照转染A375细胞,荧光显微镜下观察转染效率。用流式细胞仪检测转染后细胞增殖的变化。结果从A375细胞中成功提出miRNA。定量PCR结果显示,当转染物miR-21抑制物浓度为120nmol/L时,转染细胞内有miR-21模拟物最大程度的下调表达,2^-△△Cr值为0.80(0.65~0.92),低于对照组;当miR-494模拟物浓度为250nmol/L时,转染细胞内有miR-494模拟物最大程度的上调,2^-△△Cr值为126.82(111.52~144.22),明显高于对照组;miR-21抑制物转染组与miR-494模拟物转染组G。期细胞比率分别为(61.61±3.25)%、(61.05±3.17)%,高于对照组(P〈0.05);增殖指数分别为(38.39±3.25)%、(38.95±3.17)%,低于对照组(P〈0.05);细胞凋亡率分别为(27.74±1.39)%、(34.30±2.35)%,高于对照组(P〈0.01),细胞转染效率达90%以上。结论miR-21抑制物和miR-494模拟物促使肿瘤细胞的G,期阻滞和促进凋亡作用,miR-21可增强A375细胞增殖,有原癌基因样功能;miR-494可抑制A375细胞增殖,有抑癌基因样作用。 Objective To optimize the concentration of a microRNA-21 (miR-21) inhibitor and a miR-494 mimic for the transfection of A375 human melanoma cells, and to estimate the effect of the miR-21 inbihitor and miR-494 mimic on the proliferation of A375 cells. Methods A miR-21 inbihitor and a miR-494 mimic were designed and constructed. To optimize the concentration of the miR-21 inhihitor and miR-494 mimic for transfection, six concentrations (70 - 250 nmol/L) of the inbihitor and mimic were transfected into A375 cells separately by using Lipofectamine2000. Then, quantitative fluorescence-based PCR was performed to determine the expression of miR-21 and miR-494 in A375 cells. Some A375 cells were classified into five groups: Mock blank control group remaining untransfected, miR-21 inhibitor group transfected with the miR-21 inhibitor, miR-21 control group transfected with the miR-21 inhibitor negative control, miR-494 mimic group transfected with the miR-494 mimic, and miR-494 control group transfected with the miR-494 mimic negative control. After another 48-hour culture, the cells were collected for the analysis of cell apoptosis and cycle by using flow cytometry. Meanwhile, Cy5-1abelled miR-494 mimic negative control was transfected into A375 cells for the evaluation of the transfection efficiency by using an inverted fluorescence microscope. Results miRNAs were successfully extracted from A375 cells. As quantitative PCR revealed, the A375 cells transfected with the miR-21 inhibitor at 120 nmol/L showed the lowest expression level (2^-△△Cr) of miR-21 (average: 0.80; range: 0.65 - 0.92), and those transfected with the miR- 494 mimic at 250 nmal/L displayed the highest expression level of miR-494 (average: 126.82; range: 111.52 - 144.22). The transfection efficiency in A375 cells was higher than 90%. Compared with the corresponding negative control groups, the miR-21 inhibitor group and miR-494 mimic group showed increased apoptosis rate ((27.74± 1.39)% vs. (12.93 ± 0.65)%, (34.30 ±2.35)% vs. (15.54 ± 1.02)%, both P 〈 0.01), percentage of Gl-phase cells ((61.61 ±3.25)% vs. (50.34 ± 5.62)%, (61.05 ± 3.17)% vs. (49.95 ±2.58)%, both P 〈 0.05), but decreased proliferation index ((38.39± 3.25)% vs. (49.66 ± 5.62) %, (38.95 ± 3.17)% vs. (50.05± 2.58)%, both P 〈 0.05 ). Conclusions Both the miR-21 inhibitor and miR-494 mimic can promote the Gl-phase arrest and apoptosis in A375 cells, and miR-21 may act as a protooneogene accelerating the proliferation of A375 cells, while miR-494 may founetion as a tumor suppressor inhibiting the proliferation of A375 cells.
出处 《中华皮肤科杂志》 CAS CSCD 北大核心 2013年第10期719-722,共4页 Chinese Journal of Dermatology
基金 教育部高校博士点科研专项新教师基金(20101106120033) 山东省科技发展计划(2011GSF11847) 中央级公益性科研院所基本科研业务专项资助
关键词 黑色素瘤 MIRNA-21 miRNA-494 转染 细胞周期 细胞凋亡 Melanoma mieroRNA-21 mieroRNA-494 Transfeetion Cell cycle Apoptosis
  • 相关文献

参考文献10

  • 1Hatfield S, Ruohola-Baker H. microRNA and stem cell function. Cell Tissue Res, 2008, 331( 1 ): 57-66.
  • 2Giannakakis A, Coukos G, Hatzigeorgiou A, et al. miRNA genetic alterations in human cancers. Expert Opin Biol Ther, 2007, 7 (9): 1375-1386.
  • 3Callis TE, Chen JF, Wang DZ. MicroRNAs in skeletal and cardiac muscle development. DNA Cell Biol, 2007, 26(4): 219-225.
  • 4Rigel DS. Trends in dermatology: melanoma incidence. Arch Dermatol, 2010, 146(3): 318.
  • 5王焱,孙建方,方方,韩峻松,张国成.microRNA在人皮肤黑素瘤与色素痣中共同差异表达的研究[J].中华皮肤科杂志,2010,43(2):82-84. 被引量:3
  • 6Cheng AM, Byrom MW, Shelton J, et al. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res, 2005, 33 (4): 1290-1297.
  • 7曾维惠,郑焱,耿松梅,袁景奕,牛新武,谭升顺.COX-2抑制剂NS398对人鳞状细胞癌Tea8113细胞株生长和凋亡的影响[J].中华皮肤科杂志,2009,42(1):42-44. 被引量:2
  • 8Cui W, Iwasa K, Tokuda H, et al. Potential cancer chemopreventive activity of simple isoquinolines, 1-benzylisoquinolines, and protoberberines. Phytochemistry, 2006, 67( 1 ): 70-79.
  • 9Kunz M, Sehuhz J, Ibrahim S. Role of microRNA in melanoma progression. Melanoma Res, 2006, 16(Suppl): S53-S54.
  • 10Davis S, Lollo B, Freier S, et al, Improved targeting of miRNA with antisense oligonueleotides. Nucleic Acids Res, 2006, 34(8): 2294-2304.

二级参考文献11

  • 1曾维惠,谭升顺,雷小兵,张江安,苏宝山.环氧合酶-2在皮肤肿瘤组织中的表达及其临床意义[J].中国皮肤性病学杂志,2004,18(9):523-525. 被引量:5
  • 2Kagoura M, Toyoda M, Matsui C, et al. Immunohistochemical expression of cyclooxygenase-2 in skin cancers. J Cutan Pathol, 2001, 28(6): 298-302.
  • 3Fischer SM, Lo HH, Gordon GB, et al. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis. Mol Carcinog, 1999, 25(4): 231-240.
  • 4Cheng J, Imanishi H, Amuro Y, et al. NS-398, a selective cyclooxygenase 2 inhibitor, inhibited cell growth and induced cell cycle arrest in human hepatocellular carcinoma cell lines.Int J Cancer, 2002, 99(5): 755-761.
  • 5Meng F, Henson R, Wehbe-Janek H, et al. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology, 2007, 133 (2): 647-658.
  • 6Iorio MV, Ferracin M, Liu CG, et al. MicroRNA gene expres- sion deregulation in human breast cancer. Cancer Res, 2005, 65 16): 7065-7070.
  • 7Zhang L, Huang J, Yang N, et al. MicroRNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci USA, 2006, 103(24): 9136-9141.
  • 8Bandres E, Cubedo E, Agirre X, et al. Identification by realtime PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol Cancer, 2006, 19 (5): 29-38.
  • 9Kunz M, Schultz J, Ibrahim S. Role of microRNA in melanoma progression. Melanoma Res, 2006, 16(Suppl): S53-S54.
  • 10Tsuchiya S, Okuno Y, Tsujimoto G. MicroRNA: biogenetic and functional mechanisms and involvements in cell differentiation and cancer. J Pharmacol Sci, 2006, 101 (4): 267-270.

共引文献3

同被引文献32

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部